GP1BA and Disorder of bile acid synthesis: Druggability evaluation highlighted four protein biomarkers, ITGB2, GP1BA, ACADSB and COX6B1, which are already targeted for dry eye disease, inflammation, seizure and bile acid synthesis disorder, respectively.